Antiarrhythmic, antifibrillatory activities and reduction of infarct size after the calcium antagonist Ro 11-1781 (tiapamil) in anesthetized dogs.
D000758:Anesthesia; D000818:Animals; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006221:Halothane; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D011437:Propylamines / Q000494:pharmacology*; D013976:Tiapamil Hydrochloride; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D011437:Propylamines; D006221:Halothane; D013976:Tiapamil Hydrochloride